{{Rsnum
|rsid=3753396
|Gene=CFH
|Chromosome=1
|position=196726612
|Orientation=plus
|ReferenceAllele=A
|GMAF=0.2337
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=CFH
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 73.5 | 22.1 | 4.4
| HCB | 24.3 | 45.6 | 30.1
| JPT | 30.6 | 48.1 | 21.3
| YRI | 95.2 | 4.8 | 0.0
| ASW | 84.2 | 15.8 | 0.0
| CHB | 24.3 | 45.6 | 30.1
| CHD | 26.6 | 39.4 | 33.9
| GIH | 82.0 | 16.0 | 2.0
| LWK | 91.8 | 8.2 | 0.0
| MEX | 55.2 | 32.8 | 12.1
| MKK | 76.8 | 21.3 | 1.9
| TSI | 67.6 | 29.4 | 2.9
| HapMapRevision=28
}}
[[age related macular degeneration]] {{PMID|18421087}}

{{PMID Auto
|PMID=19162324
|Title=Genetic variants in the region harbouring IL2/IL21 associated with ulcerative colitis
}}

{{PMID|18048322|OA=1
}} A forest-based approach to identifying gene and gene gene interactions.

{{PMID|18162041|OA=1
}} Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking.

{{PMID|18483746|OA=1
}} Plasma therapy in atypical haemolytic uremic syndrome: lessons from a family with a factor H mutation.

{{PMID|19861685|OA=1
}} Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome.

{{PMID|19958499|OA=1
}} A particle swarm based hybrid system for imbalanced medical data sampling.

{{PMID|20157618|OA=1
}} Complement component 3: an assessment of association with AMD and analysis of gene-gene and gene-environment interactions in a Northern Irish cohort.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}